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a b s t r a c t
The Kelch-like ECH associated protein 1 (Keap1) is a component of a Cullin3-based Cullin-RING E3
ubiquitin ligase (CRL) multisubunit protein complex. Within the CRL, homodimeric Keap1 functions as
the Cullin3 adaptor, and importantly, it is also the critical component of the E3 ligase that performs the
substrate recognition. The best-characterized substrate of Keap1 is transcription factor NF-E2 p45-related
factor 2 (Nrf2), which orchestrates an elaborate transcriptional program in response to environmental
challenges caused by oxidants, electrophiles and pro-inﬂammatory agents, allowing adaptation and
survival under stress conditions. Keap1 is equipped with reactive cysteine residues that act as sensors for
endogenously produced and exogenously encountered small molecules (termed inducers), which have a
characteristic chemical signature, reactivity with sulfhydryl groups. Inducers modify the cysteine sensors
of Keap1 and impair its ability to target Nrf2 for ubiquitination and degradation. Consequently, Nrf2
accumulates, enters the nucleus and drives the transcription of its target genes, which encode a large
network of cytoprotective proteins. Here we summarize the early studies leading to the prediction of the
existence of Keap1, followed by the discovery of Keap1 as the main negative regulator of Nrf2. We then
describe the available structural information on Keap1, its assembly with Cullin3, and its interaction with
Nrf2. We also discuss the multiple cysteine sensors of Keap1 that allow for detection of a wide range of
endogenous and environmental inducers, and provide ﬁne-tuning and tight control of the Keap1/Nrf2
stress-sensing response.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Mammalian cells have evolved elaborate mechanisms for pro-
tection against environmental challenges, including those caused
by exposure to oxidants, electrophiles and pro-inﬂammatory
agents, which are involved in the pathogenesis of almost all
chronic disease and ageing. Deﬁciencies in these protective
mechanisms are associated with increased disease risk and accel-
erated disease progression. These systems can be upregulated by
various small molecules, termed inducers. Many of them are syn-
thesized in plants, including edible plants, and are thus present in
the human diet. Indeed, the majority of the health-promoting
properties of diets rich in fruits and vegetables have been attrib-
uted to speciﬁc phytochemicals, which are able to induce defence
systems in mammalian cells. Induction of these natural defences is
protective against damage and allows adaptation and survival un-
der conditions of stress.
One such defence system comprises a network of cytoprotective
genes, the expression of which is regulated by transcription factor
NF-E2 p45-related factor 2 (Nrf2, gene name NFE2L2) [1]. The
battery of Nrf2-regulated proteins encompasses a large number of
diverse detoxiﬁcation, antioxidant, and anti-inﬂammatory pro-
teins, as well as enzymes with essential roles in cell metabolism,
placing Nrf2 at the interface of redox and intermediary metabolism
[2]. Under homeostatic conditions, Nrf2 is a short-lived protein that
is continuously targeted for ubiquitination and proteasomal
degradation. Depending on the speciﬁc conditions, such as the
presence or absence of growth factors or endoplasmic reticulum
(ER) stress, the process of Nrf2 degradation is mediated by several
ubiquitin ligase systems, including Kelch-like ECH associated
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protein 1 (Keap1) [3], a substrate adaptor protein for Cullin3-based
Cullin-RING E3 ubiquitin ligase [4e6], b-transducin repeat-
containing protein (b-TrCP), a substrate adaptor for Skp1-Cullin1-
based Cullin-RING E3 ubiquitin ligase [7,8], and the E3 ubiquitin
ligase Hrd1 [9]. This review focuses on Keap1, which functions as a
substrate adaptor protein for the degradation of Nrf2 and serves as
an intracellular sensor for inducers, by utilising a number of reac-
tive cysteine residues.
1.1. Discovery of Keap1: historical perspective
In the early 1960s, Charles Huggins found that pretreatment
with small doses of 7,12-dimethylbenz[a]anthracene, other poly-
cyclic aromatic hydrocarbons, or of aromatic amines protects
against the toxicity and carcinogenicity of a high dose of the same
damaging agent [10,11]. In the 1970s, Lee Wattenberg showed that
similar protection can be achieved by dietary constituents,
including phytochemicals such as indole-3-carbinol, a compound
present in cruciferous vegetables, as well as phenolic antioxidants,
such as 2(3)-tert-butyl-4-hydroxyanisole (BHA), a commonly added
preservative in processed food [12]. However, the underlying
mechanism of this protection remained elusive until the studies of
Paul Talalay and Ernest Bueding. They showed that such agents are
able to induce phase 2 drug metabolising enzymes, which in turn
lead to more efﬁcient detoxiﬁcation and excretion of the pro-
carcinogens [13,14]. This phenomenon was termed “the phase 2
response” [15], or the “electrophile counterattack response” [16].
Because activation of the phase 2 response had protective effects
in various animal models of human cancer, a quantitative cell
culture-based bioassay was developed to allow for rapid screening
for potential activators, using NAD(P)H:quinone acceptor oxidore-
ductase 1 (NQO1) as a prototypic marker enzyme of the phase 2
response [17]. This assay, which became known as ‘the Prochaska
bioassay’ [18] is still widely and reliably used today to identify and
rank the inducer potencies of activators of Nrf2, including pure
compounds as well as complex mixtures, such as plant extracts. Its
application as an activity-guided fractionation led to the isolation of
the isothiocyanate sulforaphane [1-isothiocyanato-4R-(methyl-
sulﬁnyl)butane] (Fig. 1) as the principal NQO1 inducer in broccoli
[19]. Sulforaphane remains one of the most potent naturally
occurring Nrf2 activators known to date. It has shown beneﬁcial
effects in numerous animal models of human disease, and in clin-
ical trials [20e27].
Initial screens using the Prochaska cell culture bioassay as well
as rodent models revealed a bewildering array of structurally
diverse compounds able to induce NQO1 [28,29]. However, in spite
of this diversity, they all had a common chemical signature, that of
sulfhydryl reactivity. In a seminal paper published in 1988 [30], Paul
Talalay and his colleagues stated: ‘ … the capacity of an extraordi-
nary variety of seemingly unrelated anticarcinogens to induce pro-
tective enzymes can be attributed to the presence, or acquisition by
metabolism, of a simple and hitherto unrecognized chemical property:
that of a Michael reaction acceptor … ’, and further predicted the
existence in the cell of ‘ … a protein endowed with highly reactive
cysteine residue(s) that serves as the sensor for small-molecule in-
ducers of the phase 2 response’. These were courageous statements,
which were not readily embraced by the scientiﬁc community; this
was the era of ‘ligand: receptor’ interactions, and chemical reac-
tivity was yet to be recognized as a mechanism for sensing envi-
ronmental signals.
Given these early insights, when Masayuki Yamamoto and his
colleagues discovered Keap1 as the main negative regulator of Nrf2
and the expression of its downstream target genes [3], it was logical
to ask whether Keap1 contained reactive cysteine residues. Exam-
ination of its primary structure showed that Keap1 is a cysteine-
rich protein, containing 25 and 27 cysteine residues within the
mouse and the human homologues, respectively. Importantly, 10 of
these cysteines are adjacent to positively-charged amino acids;
such proximity is known to decrease the pKa of the neighbouring
cysteine sulfhydryl group and thus stabilize the thiolate anion,
maintaining the cysteine in a reactive state [31]. Because it nega-
tively regulates Nrf2 and contains reactive cysteine residues, Keap1
became the perfect candidate for the inducer sensor. Indeed, during
the subsequent years, a number of different laboratories have
identiﬁed cysteine modiﬁcations of Keap1 by numerous inducers
[reviewed in Refs. [32e34]]. It is nowwidely accepted that Keap1 is
the cysteine-based mammalian intracellular sensor for exogenous
and endogenous electrophiles and oxidants, and that cysteine
modiﬁcations of Keap1 lead to Nrf2 accumulation, nuclear trans-
location, and transcriptional upregulation of Nrf2-dependent
cytoprotective genes.
1.2. Structure of Keap1
The Keap1 protein was ﬁrst identiﬁed as a binding partner of
Nrf2 and named Keap1 based on structural similarities with the
Drosophila Kelch protein [3]. Keap1 functions as the substrate-
recognition module of a Cullin-RING ligase (CRL) E3 ligase com-
plex constructed around the Cullin3 scaffold protein. CRLs formed
around Cullin3 are unusual for two reasons. Firstly, inmost CRLs the
substrate recruitment protein associates with the N-terminus of
the Cullin scaffold protein via an adapter protein. For example the
well-characterized SCF complex (Skp, Cullin, F-box containing
complex), uses the adapter protein Skp1 to connect Cullin1 to the
substrate-recognition module, an F-box containing protein such as
Skp2 [35]. Cullin3-based E3 ligases use a single protein to act as
both the adapter and substrate-recognition protein. Secondly, the
Cullin3-CRLs function as homodimers. This feature is key to their
mechanism and so far unique among the CRLs [36e40].
Keap1 is a member of the BTB-Kelch family of proteins. It has
retained the gene name KEAP1, but is also known as KLHL19 to
conform to the naming convention of the protein family. BTB-Kelch
proteins are divided into KLHL proteins and KBTB proteins. KLHL
proteins typically consist of an N-terminal Broad complex, Tram-
track, and Bric a brac (BTB) domain, a BACK domain, and a C-ter-
minal Kelch domain made up of 5e6 Kelch motif repeats. KBTB
proteins consist of an N-terminal BTB domain and C-terminal Kelch
domain, made up of 2e4 Kelch repeats. They occasionally also have
a BACK domain.
As a member of the KLHL family, Keap1 is composed of an N-
terminal region (residues 1e49), a BTB domain (residues 50e179)
and a C-terminal Kelch domain (residues 327e611) with an inter-
vening BACK domain that is most commonly referred to as the
intervening region (IVR, residues 180e314) (Fig. 2A). There is
currently no crystal structure of the full-length Keap1 protein, but
crystal structures of individual domains and family members have
provided valuable information about the structure of Keap1.
The BTB domain is named after the Drosophila proteins Broad
complex, Tramtrack, and Bric a Brac [41]. It is also known as a POZ
domain [42]. The BTB domain is a protein-protein interaction
domain, shown to form hetero- and homo-dimers in vitro [42]. In
Keap1, as in other BTB-Kelch proteins, the BTB domain mediates
homodimer formation. The ﬁrst crystal structure of a BTB domain
to be solved was from the human protein PLZF [43]. This crystal
structure revealed a highly-symmetrical dimer interface occupying
roughly a quarter of the domain surface area. An N-terminal b-
sheet of one monomer forms a two-stranded b-sheet with a b-
strand from the main body of the neighboring monomer. The
structures of a number of other BTB domains have shown that this
interface is well conserved, including the BTB domain of Keap1, the
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structure of which was recently reported (Fig. 2B) [44].
The BACK domain was originally deﬁned as a conserved region
occurring in proteins with BTB domains and C-terminal Kelch re-
peats [45]. Sequence analysis predicted that the domain would be
entirely helical. The structure of the Keap1 IVR (a BACK domain) has
yet to be solved, but crystal structures of the BACK domains of
KLHL3 and KLHL11 are available [46,47]. They conﬁrm that the
domain is entirely helical and show that the domain is highly
extended, presumably to position the Kelch domain correctly for
substrate recruitment.
At the N-terminal end of the IVR is a bihelical motif known as
the ‘3-box’ [39]. The 3-box is a crucial structural element required
for the interaction between Keap1 and Cullin3. The BTB domain
with a C-terminal 3-box are sufﬁcient for BTB-Cullin3 assembly, but
in experiments using the BTB-MATH protein SPOP, the deletion of
the 3-box resulted in more than a 10-fold drop in the afﬁnity of
SPOP for Cullin3 [39].
The Kelch domain is located at the C-terminus of Keap1.
Numerous crystal structures of the Keap1 Kelch domain have now
been solved, driven in part by an interest in targeting the domain
with small molecule inhibitors [48e57]. The domain is made up of
6 Kelch repeats, each of which forms one of the ‘blades’ of a highly-
symmetrical 6-bladed b-propeller, with a narrow solvent-ﬁlled
channel at the center. Each blade is a four-stranded antiparallel
twisted b-sheet. The propeller is closed via a ‘C-terminal strand
closure’ mechanism: three of the strands that make up blade 1 are
from the N-terminal end of the sequence, while the fourth is from
the C-terminal end. This forms a stable interface between blades 1
and 6 (Fig. 2C). Structures of additional Kelch domains have shown
that this blade-closure arrangement is a common feature of Kelch
domains [47,58]. At the top of the domain is a shallow, positively-
charged recess that functions as the substrate-binding pocket.
Keap1 homodimerizes via the BTB domain, employing an
interface very similar to that of the PLZF BTB domain, despite
limited sequence identity between the two domains [43,44]. A
CryoEM reconstruction of the mouse Keap1 protein revealed it to
be a highly-symmetric dimer resembling a ‘pair of cherries’ [40].
The two Kelch domains are joined by a ‘stem’ of the BTB and IVR
regions, positioning the two substrate binding pockets approxi-
mately 95 Å apart. The symmetry axis is the BTB dimer interface.
1.3. Assembly of Keap1 with Cullin3
Keap1 associates with the N-terminal domain of Cullin3 via the
BTB domain and 3-box. Crystal structures of BTB proteins in com-
plex with Cullin3 have shown the interface in detail [46,47,59].
Similar to other Cullin proteins, the N-terminal domain of Cullin3 is
composed of three ‘Cullin repeats’. Each repeat consists of a ﬁve-
helix bundle motif. The N-terminal end of this domain interacts
with the BTB domain, 3-box and IVR of Keap1, projecting away from
the ‘stem’ of the Keap1 dimer at roughly a 45 angle. Helices a2 and
a5 pack up against the surface of Keap1. An 8-residue strand N-
terminal to helix a1 extends across the width of the domain,
running along the top of the 3-box and contacting the BTB and IVR
Fig. 1. Examples of small-molecule Nrf2 activators that react with cysteine sensors of Keap1. Shown are model structures of the isothiocyanate sulforaphane [1-isothiocyanato-4R-
(methylsulﬁnyl)butane], the double Michael acceptor HBB2 [bis(2-hydroxybenzylidene)acetone], and the cyanoenones TP-225 [2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile],
TBE-31 [(±)-(4bS,8aR,10aS)-10a-ethynyl-4b,8,8-trimethyl-3,7-dioxo-3.4b,7,8,8a,9,10,10a-octahydrophenanthrene-2,6-dicarbonitrile], MCE-1 [3-ethynyl-3-methyl-6-oxocyclohexa-
1,4-dienecarbonitrile] and MCE-5 [3,3,5,5-tetramethyl-6-oxocyclohex-1-enecarbonitrile].
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domains. In studies with Cullin3 and KLHL11, deletion of the resi-
dues N-terminal to the a1 helix resulted in over a 30-fold reduction
in afﬁnity [47]. This is a feature crucial to the Cullin3-BTB interac-
tion, presumably necessary to compensate for the lack of Skp1-type
adapter proteins in Cullin3 based CRLs. The Cullin3 C-terminal
domain supports a RING protein such as Rbx1, which is required to
recruit an activated E2 ubiquitin-conjugating enzyme. No crystal
structures have yet been solved of full-length Cullin3, but crystal
structures have been solved of several CRL complexes constructed
around full-length Cullins and isolated Cullin C-terminal domains
in complex with RING proteins such as Rbx1, showing the general
structure of full-length Cullin proteins and the Cullin-RING inter-
face [35,60e65]. The Cullin C-terminal domain is a globular domain
that engages a RING protein via a 5-stranded b-sheet in which the
second strand is the N-terminal b-sheet of the associated RING
protein [35,60e65]. Experiments using size-exclusion chromatog-
raphy and analytical ultracentrifugation to study a recombinantly-
expressed Keap1/Cullin3/Rbx1 complex showed that two mole-
cules of Keap1 assemble with one molecule of Cullin3 and Rbx1, a
2:1 stoichiometry [66]. However, experiments using the BTB pro-
tein SPOP in complex with Cullin3 found that the two proteins
assemble with a 2:2 stoichiometry [39], and an in vitro assay con-
ducted using Keap1:Cullin3 and SPOP:Cullin3 complexes suggested
that both complexes assemble with a 2:2 stoichiometry [67].
Additionally, multiple crystal structures have now been solved of
BTB proteins in complex with Cullin3 that all show a 2:2 stoichi-
ometry [46,47,59]. This evidence suggests that Cullin3 binds to
Keap1 with 2:2 stoichiometry, and consequently the complex
forms a homodimer with the BTB domain of Keap1 functioning as
the interface (Fig. 2D).
1.4. The Keap1/Nrf2 interaction
The dimeric architecture of the complex is central to its function.
Fig. 2. (A) Domain organization of human Keap1. The locations of the 27 cysteine residues are indicated. (B) The crystal structure of the Keap1 BTB domain (PDB ID: 4CXI). One
monomer is coloured as in (A) and the neighbouring monomer coloured grey to highlight the dimer interface. (C) Crystal structure of the Keap1 Kelch domain (PBD ID: 2FLU),
coloured blue to red from N- to C-terminus. The 6 ‘blades’ of the propeller are indicated and numbered. (D) Cartoon representation of the complete Keap1/Cullin3 E3 ligase complex.
The Keap1 dimer engages a single molecule of Nrf2 via the ETGE and DLG motifs and associates with Cullin3, which engages a RING protein such as Rbx1 with the C-terminal
domain. Rbx1 recruits an activated E2, which is then able to polyubiquitinate the bound Nrf2, resulting in Nrf2 degradation. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
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Two molecules of Keap1 engage a single molecule of the substrate,
Nrf2. Each of the Kelch domains binds to one of two motifs in the
Nrf2 protein, known as the ETGE and DLG motifs [37]. These two
motifs are situated at either side of a central lysine-rich a-helix, so
that binding to Keap1 positions the central helix in the middle of
the complex ready for the attachment of ubiquitins from the acti-
vated E2 enzymes on either side (Fig. 2D). It is thought that Nrf2
interfaces with Keap1 via a proposed ‘hinge-and-latch’ mechanism
[52]. The ETGE motif folds into a b-turn and inserts into the sub-
strate binding pocket of the Keap1 Kelch domain, forming speciﬁc
electrostatic interactions between the sidechains of E79 and E82 of
Nrf2 and several Keap1 residues lining the substrate binding
[50,51]. The DLG motif binds to the opposite Kelch domain in a
similar binding mode to the ETGE motif but with an afﬁnity 200-
fold lower [37,55]. Thermodynamic analysis revealed that the
ETGE motif binds with a much slower on/off rate than the DTG
motif, but both motifs are necessary for activity [36,55]. In this way
the ETGE is thought to function as the ‘hinge’ and the DTG motif as
the ‘latch’, positioning the Nrf2 lysine-rich helix for ubiquitination
[68].
Under basal conditions, the dimeric Keap1 CRL complex engages
an Nrf2 molecule. Covalent attachment of a Nedd8 protein to a
highly-conserved lysine in the Cullin3 C-terminal domain leads to a
reconﬁguration of the complex that optimally positions the asso-
ciated E2 enzymes above the bound Nrf2, leading to its poly-
ubiquitination and subsequent degradation by the proteasome
[47,62,69]. Exposure to electrophiles or reactive oxygen species
causes the cessation of polyubiqutination. The reactive ‘sensor’
cysteine residues in Keap1 are modiﬁed. The ‘hinge-and-latch’
model states that this reduces the afﬁnity of Keap1 for Nrf2 but
does not lead to release. Instead, newly-synthesized Nrf2 is trans-
located to the nucleus, triggering the transcription of Nrf2-
dependent genes [52,68]. More recently, an alternative model
was proposed known as the ‘conformation cycling’ model. This
model posits that Keap1 uses a cyclic mechanism to target Nrf2 for
ubiquitination and proteasomal degradation (Fig. 3A) [70,71]. An
important feature of this cyclic mechanism is that it ensures
regeneration of Keap1, which allows the cycle to proceed. Inducers
bind and chemically modify speciﬁc reactive cysteine residues of
Keap1, or directly disrupt the protein: protein interaction between
Keap1 and Nrf2, thus blocking the cycle of Keap1-dependent Nrf2
degradation. This block allows de novo synthesized Nrf2 to accu-
mulate, translocate to the nucleus, and initiate transcription of
Nrf2-dependent cytoprotective genes (Fig. 3B).
1.5. The cysteine sensors of Keap1: lessons from experiments with
puriﬁed recombinant Keap1
The discovery of Keap1 as a negative regulator of Nrf2 made it
possible to test the idea that cysteine residues of Keap1 serve as the
sensors for inducers. As mentioned above, Keap1 is a cysteine-rich
protein (Fig. 4), and the 27 cysteine residues in the human protein
are all reactive to varying degrees [72]. Initial experiments
employed ultraviolet-visible (UV-VIS) spectrophotometry and
compared the spectral changes of various inducers upon addition of
puriﬁed recombinant Keap1. In this way, it was shown that Keap1
binds directly to inducers of three different classes, i.e., the iso-
thiocyanate sulforaphane, the double Michael acceptor bis(2-
hydroxybenzylidene)acetone, as well as a number of cyanoe-
nones: the pentacyclic TP-225, the tricyclic TBE-31, and the
monocyclic MCE-1 and MCE-5 [73e75] (Fig. 1). Notably, although
such inducers bind to Keap1 covalently, the reaction is readily
reversible [76], which makes them suitable for chronic in vivo
administration [77].
A mass-spectrometry approach to detect covalent adducts in
Keap1 required incubation with an inducer that binds to cysteines
irreversibly, and the steroid dexamethasone 21-mesylate (Dex-
mes) was initially used. This led to identiﬁcation of four cysteine
residues (C257, C273, C288 and C297) within the IVR domain, and a
ﬁfth one, C613 in the C-terminal region of murine Keap1, all of
which were modiﬁed when puriﬁed recombinant murine Keap1
was incubated with Dex-mes [73]. Incubation of human Keap1with
two separate biotin-tagged electrophiles, N-iodoacetyl-N-bio-
tinylhexylenediamine (IAB) or 1-biotinamido-4-(4‘-[mal-
eimidoethylcyclohexane]carboxamido)butane (BMCC), led to
cysteine modiﬁcations of Keap1, but in each case, the spectrum of
the modiﬁed cysteines was different, as analyzed by liquid
chromatography-tandem mass spectrometry. Thus, Eggler et al.
[78] reported that IAB alkylated most readily C151, C288, and C297,
followed by C319, C257, C273, and C613. Using somewhat different
reaction conditions, Hong et al. [79] showed that IAB modiﬁed
primarily the IVR cysteines C196, C226, C241, C257, C288, as well as
C319, whereas BMCC reacted with C196 and C249 in the IVR, C77 in
the BTB domain, and with C368 and C489 in the Kelch domain.
Unlike the stable alkylation adducts formed by Dex-mes, IAB
and BMCC, binding of the dietary isothiocyanate sulforaphane to
Keap1 leads to the formation of unstable thionoacyl adducts, which
are labile to hydrolysis and transacylation reactions. To allow for
detection of these adducts, a liquid chromatography-tandem mass
spectrometry method was developed and further optimised to
minimize adduct decomposition [80]. It was found that sulfo-
raphanemodiﬁed cysteine residues in puriﬁed recombinant human
Keap1, mainly in the Kelch domain. The most consistently modiﬁed
cysteine was C489, followed by C513, C518, and C583. Adducts with
the IVR cysteines C226 and C249, as well as with C77 located in the
BTB domain, and C624 in the C-terminal region, were also detected.
A subsequent study showed that by modifying the conditions for
incubation and sample processing (eliminating the iodoacetamide
treatment step and thus reducing the possibility for competition
with sulforaphane for the formation of reversible sulforaphane-
cysteine adducts, as well as shortening the sample preparation
time), C151 could be also detected as one of the four (C38, C151,
C368 and C489) most readily modiﬁed cysteine residues in Keap1
by sulforaphane [81]. In addition to sulforaphane, C151 is also the
most reactive cysteine in Keap1 towards three other electrophilic
natural products, xanthohumol, isoliquiritigenin, and 10-shogaol,
all of which activate Nrf2 [82].
Together, the experiments with puriﬁed recombinant Keap1
established that cysteine residues in Keap1 serve as sensors for a
variety of inducers. However, depending on the reaction conditions
and the type of the inducer, multiple cysteine residues could be
modiﬁed. It was next important to determine which of these
cysteine residues function as inducer sensors in the context of the
cellular environment. This question was addressed by employing
both genetic and pharmacologic means. Due to its low abundance,
the next set of experiments required ectopic expression of Keap1 in
cells.
1.6. The cysteine sensors of Keap1: lessons from experiments with
ectopically expressed Keap1 and its mutants in mammalian cells
The use of ectopically-expressed Keap1 or of Keap1 carrying
mutations in some of the identiﬁed inducer-modiﬁed cysteine
residues revealed that substitution of C273 or C288 with either
serine or alanine (i.e., C237A/S and C288A/S) rendered Keap1 un-
able to repress Nrf2 activity under homeostatic conditions in cells
[83e85]. This ﬁnding was further conﬁrmed in vivo by generating
transgenic mice expressing either C273A or C288A Keap1 mutants
[86]. The inability of these Keap1 mutants to repress Nrf2 corre-
latedwith reduced ubiquitination of Nrf2, but did not affect binding
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of Keap1 to Nrf2 or Cullin3 [5,6,87], suggesting that modiﬁcation of
C273 and C288 by inducers could decrease the rate of ubiquitina-
tion and degradation of Nrf2. A recent study systematically intro-
duced amino acid substitutions of C273 and C288, and found that
C273W and C288N mutations did not affect the ability of Keap1 to
repress Nrf2 [88]. This ﬁnding allowed generation of stable mouse
embryonic ﬁbroblast (MEF) cell lines for testing of the functional
importance of C273 and C288 in inducer sensing, which previously
Fig. 3. The cycle of Keap1-mediated degradation of Nrf2. (A) At homeostatic conditions, Keap1 uses a cyclical mechanism to target Nrf2 for ubiquitination and degradation, whereby
the Neh2 domain of de novo synthesized Nrf2 binds sequentially to the Kelch domains of the Keap1 dimer, ﬁrst through its high afﬁnity “ETGE” binding motif to form the open
conformation of the Keap1: Nrf2 protein complex, followed by the low afﬁnity “DLG” binding motif to form the closed conformation. In the closed conformation of the protein
complex, Nrf2 is ubiquitinated and subsequently degraded through the proteasome. Free Keap1 is regenerated, allowing the cycle to start again. (B) Electrophiles and oxidants
(inducers) block the cycle of Keap1-mediated degradation of Nrf2 by chemically modifying cysteine sensors of Keap1 and disabling its substrate adaptor function, leading to
accumulation of the protein complex in the closed conformation. As a result, Nrf2 is not degraded, and Keap1 is not regenerated. This allows de novo synthesized Nrf2 to accumulate,
translocate to the nucleus, heterodimerize with a small Maf transcription factor (sMaf), and initiate transcription of downstream target genes.
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had been not been possible due to the loss-of-function phenotype
of the C273A/S and C288A/S mutants.
In stark contrast with the loss-of-function phenotype of the
C237A/S and C288A/S mutants of Keap1, mutation of C151 to serine
rendered Keap1 a constitutive repressor of Nrf2 at both homeo-
static and induced states in cells [83] and in transgenic mice [86].
C151 was found to be indispensable for sensing the classical in-
ducers sulforaphane and tert-butyl hydroquinone (tBHQ), but not
for sensing other inducers such as the environmental toxin arsenite
[89] or the endogenous cyclopentene prostaglandin 15-deoxy-
D12,14-prostaglandin J2, (15-dPGJ2), which is dependent on C273
[90] or C288 [88]. Together, these ﬁndings started to shed light on
the existence of a degree of speciﬁcity, i.e. that speciﬁc cysteine
residues in Keap1 may form discrete sensors, which ‘respond’ to
certain types of inducers. This possibility was addressed by
McMahon and colleagues [91]. Using ectopically expressed murine
Keap1 in mammalian cells, these researchers found that C151 and
C288 formed the basis for two discrete cysteine sensors. In addi-
tion, a third sensor, termed ‘zinc sensor’, is formed by H225, C226
and C613. Each of the three sensors shows speciﬁcity for certain
inducers (see below). This complexity of responses has given rise to
the idea of a ‘cysteine code’, the hypothesis that different inducers
modify speciﬁc combinations of cysteines in order to tightly control
the Keap1/Nrf2 stress-sensing response [32,92e94].
It is now clear that C151 is required for sensing of nitric oxide,
sulforaphane, tBHQ, diethylmaleate, dimethylfumarate, and CDDO-
Im [83,88,91,95]. C288 responds to the cyclopentenone prosta-
glandins 15-dPGJ2 and prostaglandin A2 (PGA2), the electrophilic
nitro-oleic acid (OA-NO2) [88], the alkenals acrolein and 4-
hydoxynonenal [91], and daillyl trisulﬁde, a volatile component of
garlic oil [96]. H225, C226 and C613 comprise the sensor for Zn2þ,
Cd2þ, Se4þ, As3þ [91], and H2S [97]. The ability of Keap1 to sense
Zn2þ is consistent with a previous report, which found that re-
combinant Keap1 binds Zn2þ stoichiometrically, with an associa-
tion constant of 1011 M1 [98]. A study with sulfoxythiocarbamate
alkyne (STCA), an analog of sulforaphane, in which the isothiocy-
anate group is replaced by a sulfoxythiocarbamate group that forms
stable thiocarbamate adducts with cysteine residues, identiﬁed
C273, C288 and C613 of ectopically expressed Keap1 as being
modiﬁed by this mildly electrophilic inducer [99]. Inhibition of
Keap1 by H2S was found to be facilitated by the formation of an
intramolecular disulﬁde bridge between C226 and C613 [97].
Notably, among the sensor cysteines of Keap1, C151 is best
characterized. Evidence from a number of studies has suggested
that C151 is the most reactive and critical to the Keap1/Nrf2 stress-
sensing response [6,78,83]. As described above, C151 has been
identiﬁed as the most frequently modiﬁed by Nrf2-activating
agents in mass spectrometry studies [82,100]. C151 is located in
the BTB domain, at the N-terminal end of the a5 helix, and is
thought to be highly reactive as a result of its environment, as it is
surrounded by basic residues (H129, K131, R135, K150, and H154),
which lower the pKa of C151, enabling it to exist as the thiolate
anion at physiological pH (Fig. 4). Mutagenesis studies showed that
exchanging many of these residues for methionine results in a
signiﬁcant reduction in C151 reactivity [91]. A model was proposed
suggesting that covalent modiﬁcation of C151 caused a dissociation
of the Keap1/Cullin3 heterodimer, consequently blocking Nrf2
ubiquitination [101,102]. However, a crystal structure of the Keap1
C151W mutant BTB domain, designed to mimic a modiﬁed C151,
showed no conformational changes that would impact Cullin3
binding [44], and data from live cells showed no evidence that the
mechanism involves a Keap1/Cullin3 dissociation [70,103]. An
alternative model suggests that modiﬁcation of the sensor cyste-
ines triggers a conformational change in Keap1 but not the disso-
ciation of Nrf2 or Cullin3 [98,104]. This is supported by experiments
using a hydrophobicity probe, which showed that the hydropho-
bicity of recombinant Keap1 (determined by the intrinsic trypto-
phan ﬂuorescence) decreases upon addition of the cysteine-
reactive inducers 4,4’-dipyridyl disulﬁde and sulforaphane [98].
However, the exact nature of this conformational change is still
unclear.
Although less extensively studied, two other cysteines located in
the Kelch domain, i.e. C434 and C368, are also reactive. Both of
these residues were shown to be modiﬁed by glutathione, and
Fig. 4. Model of the complete Keap1 structure, using the structure of the KLHL11 BTB and BACK domains (PDB ID: 3I3N) as the BTB and IVR domains and the Keap1 Kelch domain in
complex with either the ETGE motif (PDB ID: 2FLU) or the DLG motif (PDB ID: 3WN7). Domains are coloured as in Fig. 2A. The Keap1 cysteine residues have been modelled onto the
KLHL11 structure and numbered as in the human Keap1 sequence. The inset panel shows the environment of the highly-reactive C151 (PDB ID: 4CXI), with the surrounding basic
residues shown as sticks and numbered.
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molecular modeling has indicated that the consequences of such
modiﬁcation would alter the conformation of the Kelch domain in
such a way as to block the Keap1/Nrf2 interaction [72]. In addition,
C434 was shown to be modiﬁed by a nitrated derivative of cGMP, 8-
nitroguanosine 30,5'-cyclic monophosphate (8-nitro-cGMP), lead-
ing to Nrf2 activation [105]. Overall, it is now clear that Keap1
utilizes multiple cysteine residues as sensors for detection of awide
range of endogenous and environmental inducers.
1.7. The fate of Keap1 after sensor cysteine modiﬁcation
To address the fate of Keap1 after modiﬁcation of its sensor
cysteine(s), Hong et al. [79] used ectopically expressed FLAG-Keap1
in HEK293 cells. Treatment with IAB or tBHQ led to formation of
high molecular weight Keap1 species, which were identiﬁed as K-
48-linked polyubiquitin conjugates by immunoblotting and liquid
chromatography tandem mass spectrometry. Coincidentally with
Keap1 polyubiquitination, Nrf2 stabilization and nuclear accumu-
lation were observed. A model was proposed according to which
Keap1 cysteine modiﬁcation by electrophiles triggers a switch of
Cullin3-dependent ubiquitination from Nrf2 to Keap1, ultimately
leading to Nrf2 activation. More recently, Taguchi et al. [106] pro-
posed a different model. These authors showed that under condi-
tions of autophagy deﬁciency (i.e. in livers of Atg7-or p62-deﬁcient
mice), the levels of Keap1 are increased. Nutrient starvation in
human hepatoma (HepG2) cells caused a decrease in the levels of
Keap1. Together, these results suggest that Keap1 is degraded
through autophagy in a p62-dependent manner. Exposure to
electrophiles, such as tBHQ, shortens the half-life of Keap1. The
authors proposed that autophagy-mediated accelerated turnover of
Keap1 contributes to the recovery of the Keap1 activity after
modiﬁcation of its sensor cysteine(s) by electrophiles.
Some of the most potent electrophilic inducers, such as the
isothiocyanates and the cyanoenones induce cytoprotective re-
sponses in the order of their electron afﬁnity [107] and bind to
cysteine in a reversible manner [76], and may cause formation of
disulﬁde bond(s) in Keap1. It is therefore possible that such cysteine
modiﬁcation(s) of Keap1 can be reversed by the concomitant in-
creases in the intracellular levels of glutathione and thioredoxin/
thioredoxin reductase systems, both of which are Nrf2 transcrip-
tional targets. This notion is supported by the ﬁnding that simul-
taneous inactivation of the glutathione (by chemical inhibition) and
thioredoxin (by shRNA-mediated knockdown of thioredoxin
reductase 1) systems leads to constitutive Keap1 oxidation [108].
Thus, it is possible that in contrast to irreversibly modiﬁed Keap1
which is destroyed by ubiquitination/proteasomal degradation
and/or autophagy and needs to be replenished by de novo synthesis,
reversible modiﬁcation(s) of Keap1 allow for regeneration of the
inducer sensor.
2. Conclusions
There is no longer any scepticism regarding the existence in the
cell of ‘… a protein endowed with highly reactive cysteine residue(s)
that serves as the sensor for small-molecule inducers of the phase 2
response’. Several decades of research by multiple independent
groups have convincingly demonstrated that this protein is Keap1.
Furthermore, the extraordinary ability of Keap1 to accommodate
inducers of many different shapes and sizes, and with varying de-
grees of reactivity, has given rise to a ‘cysteine code’, which ensures
ﬁne tuning and tight control of the Keap1/Nrf2 stress-sensing
response. This response is the intended target for small molecule
activators of several different chemical classes, some of which are
currently in clinical trials. Further research is essential for detailed
understanding of the precise consequences of targeting Keap1 for
disease prevention and treatment. Acknowledgments We are
extremely grateful to Cancer Research UK (C20953/A18644) and
the BBSRC (BB/J007498/1) for ﬁnancial support.
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